eHealth for patients with rare diseases: the eHealth Working Group of the European Reference Network on Rare Multisystemic Vascular Diseases (VASCERN).

European commission 3rd health programme European reference network Knowledge exchange Orphan diseases Rare diseases Telemedicine Vascular diseases eHealth mHealth

Journal

Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602

Informations de publication

Date de publication:
08 04 2021
Historique:
received: 01 11 2019
accepted: 03 11 2020
entrez: 9 4 2021
pubmed: 10 4 2021
medline: 29 6 2021
Statut: epublish

Résumé

The European Reference Network on Rare Multisystemic Vascular Diseases (VASCERN) was launched in 2017 and involves, to date, 35 highly specialised multidisciplinary expert centres (from the 30 full Healthcare Provider members) coming from 11 countries and more than 70 patient organizations from 16 countries. The eHealth Working Group (WG) of VASCERN was set up to develop practical, patient-centred solutions and strategies for effective use of eHealth tools to answer the needs of patients with multisystemic vascular rare diseases. Following the identified patients' needs and following the guiding principles of collaboration and patient-centredness, the eHealth WG was created with the following aims: to develop a mobile app to help patients find expert centres and patient organizations, and to develop resources (Pills of Knowledge, PoK) for training and education via digital platforms (eLearning). The mobile app includes, to date, functionalities that allow users to find expert centres and patient organizations across Europe in the area of rare multisystemic vascular diseases. Discussed app developments include personalized digital patient passports, educational material, emergency management guidelines and remote consultations. Regarding training and education, a variety of PoK have been developed. The PoK cover several topics, target several user groups, and are delivered in various formats so that they are easy-to-use, easy-to-understand, informative, and viable for delivery and sharing through digital platforms (eLearning) including, e.g., the VASCERN YouTube™ channel. Overall, the work carried out by the eHealth WG of VASCERN can be seen as a pilot experience that may serve as a basis to for collaborative development of patient-centred eHealth tools that answer the needs of patients with various rare diseases, not limited to rare multisystemic vascular diseases. By expanding the multidisciplinary approach here described, clinical and research networks can take advantage of eHealth services and use them as strategic assets in achieving the ultimate goal of ensuring equity of access to prevention programs, timely and accurate diagnosis and specialized care for patients with rare diseases throughout Europe.

Sections du résumé

BACKGROUND
The European Reference Network on Rare Multisystemic Vascular Diseases (VASCERN) was launched in 2017 and involves, to date, 35 highly specialised multidisciplinary expert centres (from the 30 full Healthcare Provider members) coming from 11 countries and more than 70 patient organizations from 16 countries. The eHealth Working Group (WG) of VASCERN was set up to develop practical, patient-centred solutions and strategies for effective use of eHealth tools to answer the needs of patients with multisystemic vascular rare diseases.
THE EHEALTH WG
Following the identified patients' needs and following the guiding principles of collaboration and patient-centredness, the eHealth WG was created with the following aims: to develop a mobile app to help patients find expert centres and patient organizations, and to develop resources (Pills of Knowledge, PoK) for training and education via digital platforms (eLearning). The mobile app includes, to date, functionalities that allow users to find expert centres and patient organizations across Europe in the area of rare multisystemic vascular diseases. Discussed app developments include personalized digital patient passports, educational material, emergency management guidelines and remote consultations. Regarding training and education, a variety of PoK have been developed. The PoK cover several topics, target several user groups, and are delivered in various formats so that they are easy-to-use, easy-to-understand, informative, and viable for delivery and sharing through digital platforms (eLearning) including, e.g., the VASCERN YouTube™ channel.
CONCLUSION
Overall, the work carried out by the eHealth WG of VASCERN can be seen as a pilot experience that may serve as a basis to for collaborative development of patient-centred eHealth tools that answer the needs of patients with various rare diseases, not limited to rare multisystemic vascular diseases. By expanding the multidisciplinary approach here described, clinical and research networks can take advantage of eHealth services and use them as strategic assets in achieving the ultimate goal of ensuring equity of access to prevention programs, timely and accurate diagnosis and specialized care for patients with rare diseases throughout Europe.

Identifiants

pubmed: 33832526
doi: 10.1186/s13023-020-01604-4
pii: 10.1186/s13023-020-01604-4
pmc: PMC8034087
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

164

Références

Orphanet J Rare Dis. 2019 Nov 21;14(1):264
pubmed: 31752940
Gene Ther. 2017 Sep;24(9):562-571
pubmed: 28440796
Eur Heart J. 2016 Jan 1;37(1):63-6
pubmed: 26303835
PLoS One. 2017 Feb 24;12(2):e0172532
pubmed: 28234950
Orphanet J Rare Dis. 2017 Mar 31;12(1):63
pubmed: 28359278
Orphanet J Rare Dis. 2019 Jan 24;14(1):21
pubmed: 30678705
Orphanet J Rare Dis. 2020 Apr 25;15(1):103
pubmed: 32334637
Eur J Pediatr Surg. 2017 Oct;27(5):388-394
pubmed: 28977810
Orphanet J Rare Dis. 2015 Apr 09;10:41
pubmed: 25887544
Orphanet J Rare Dis. 2020 Jun 29;15(1):165
pubmed: 32600364
Orphanet J Rare Dis. 2016 Feb 24;11:17
pubmed: 26911987
Orphanet J Rare Dis. 2019 Aug 28;14(1):210
pubmed: 31462308
Blood Transfus. 2014 Apr;12 Suppl 3:s621-5
pubmed: 24922304
Orphanet J Rare Dis. 2018 Aug 15;13(1):136
pubmed: 30111344
Orphanet J Rare Dis. 2017 Aug 7;12(1):137
pubmed: 28784158
BMC Health Serv Res. 2016 Aug 09;16(a):363
pubmed: 27507250

Auteurs

Alessia Paglialonga (A)

Institute of Electronics, Information Engineering and Telecommunications (IEIIT), Italian National Research Council (CNR), Milan, Italy.

Raffaella Gaetano (R)

Italian National Research Council (CNR), Institute of Biomedical Research and Innovation (IRIB), Palermo, Italy.

Leema Robert (L)

Department of Clinical Genetics, VASCERN HTAD European Reference Centre, Guys and St Thomas NHS Foundation Trust, London, UK.

Marine Hurard (M)

VASCERN Coordination Project-Team, Assistance Publique-Hôpitaux de Paris Hôpital Bichat-Claude Bernard, VASCERN HTAD European Reference Centre, Paris, France.

Luisa Maria Botella (LM)

Asociación HHT España, Almansa, Spain.
VASCERN European Patient Advocacy Group (ePAG), Paris, France.

Natasha Barr (N)

VASCERN Coordination Project-Team, Assistance Publique-Hôpitaux de Paris Hôpital Bichat-Claude Bernard, VASCERN HTAD European Reference Centre, Paris, France.

Guillaume Jondeau (G)

VASCERN Coordinator, Cardiology Department, Reference Center for Marfan Syndrome and Related Diseases, INSERM U1148 LVTS, Assistance Publique-Hôpitaux de Paris, Université de Paris, Hôpital Bichat-Claude Bernard, VASCERN HTAD European Reference Centre, Paris, France.

Alessandro Pini (A)

Cardiovascular-Genetic Center, IRCCS Policlinico San Donato, Via Morandi 30, 20097, San Donato Milanese, MI, Italy. alessandro.pini@grupposandonato.it.
VASCERN eHealth Working Group, Past Chair, Paris, France. alessandro.pini@grupposandonato.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH